Drugs / Cetuxima-β
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06959693 | Jun 2025 → Sep 2028 expected | colorectal cancer | Sun Yat-sen University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cetuxima-β | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06959693 ↗ |
| Route | Intravenous | “initial intravenous infusion (IV)\>120 min, subsequent IV \>60 min” NCT06959693 ↗ |